Re-establishing self-tolerance by targeting MHC class II-restricted autoimmunity

Javier clemente-casares

Nationality Spanish

Year of selection 2010

Institution University of Calgary

Country Canada

Risk Health


3 years

120000 €

A nanovaccine for juvenile diabetes

Juvenile diabetes is an autoimmune disease resulting from an attack that destroys pancreatic cells that secrete insulin. Javier Clemente Casares is studying a therapeutic approach that could lead to a nanovaccine for the disease.

To add or modify information on this page, please contact us at the following address: